Viewing Study NCT01830556


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2025-12-25 @ 8:53 PM
Study NCT ID: NCT01830556
Status: UNKNOWN
Last Update Posted: 2013-05-21
First Post: 2013-04-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Karolinska University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module